Remaining Agile in the COVID-19 pandemic healthcare landscape – How we adopted a hybrid telemedicine Geriatric Oncology care model in an academic tertiary cancer centerArticle Published on 2022-07-012023-07-08 Journal: Journal of geriatric oncology [Category] COVID19(2023년), [키워드] COVID19 Geriatric Oncology pandemic telehealth Telemedicine [DOI] 10.1016/j.jgo.2022.04.006 PMC 바로가기
Usefulness of chest X-rays for detecting COVID 19 pneumonia during the SARS-CoV-2 pandemicObservational Study Published on 2022-07-012022-10-05 Journal: Radiología [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] analyzed chest X-ray clinical suspicion coronavirus COVID 19 COVID19 cross-sectional Cuidados intensivos discharged English form hospital Hospitalized ICU intensive care material Mild Pandemia pandemic pathologic Patient patients hospitalized Pneumonia polymerase chain polymerase chain reaction positive Prevalence Probability prognostic prognostic variable Radiografía Radiología radiology Reacción en cadena de la polimerasa RT-PCR SARS-CoV-2 SARS-COV-2 infection sensitivity Spanish statistically significant difference the disease the SARS-CoV-2 two group variable was done x-rays [DOI] 10.1016/j.rxeng.2021.11.003 PMC 바로가기 [Article Type] Observational Study
Recapitulating infection, thermal sensitivity and antiviral treatment of seasonal coronaviruses in human airway organoids인간 기도 오르가노이드에서 계절성 코로나바이러스의 감염, 열 민감도 및 항바이러스 치료 요약Article Published on 2022-07-012022-09-11 Journal: EBioMedicine [Category] 치료제, [키워드] 229E Airway organoids Analysis antiviral activity antiviral therapy Antiviral treatment approved conditions Coronavirus infection Coronavirus infections COVID COVID19 development experimental model facilitate favor funding help host response Human human airway Infection infections Infectious virus inhibited interactions Kinetics medication medications Mild molnupiravir Netherland NL63 OC43 occur organization Organoid Pathogenesis phenotype populations Remdesivir replicate Replication Research research and development resulting RNA sequencing robust seasonal seasonal coronavirus seasonal coronaviruses severe complication severe complications Society Support supported temperature tested therapeutic thermal Thermal sensitivity Transcriptome transcriptomic Transmissibility upper respiratory tract viral replication virus replication Virus-host interaction Virus-host interactions was performed was tested [DOI] 10.1016/j.ebiom.2022.104132 PMC 바로가기 [Article Type] Article
SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine1차 항체 결핍에서 SARS-CoV-2-특이적 및 기능적 세포독성 CD8 세포: 자연 감염 및 백신에 대한 반응Article Published on 2022-07-012022-09-12 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] analyzed CD107a CD8 CD8 T cell clearance Control COVID-19 COVID-19 infection COVID-19 mRNA Vaccination COVID-19 vaccine COVID19 Critical CTL CTLs CVID cytotoxic Cytotoxic T cell deficiency dose evaluated examined flow cytometry functional granzyme B healthy healthy control immunodeficiency infected cells Infection isotype control monoclonal antibody mRNA vaccine natural natural infection Patient patients with CVID Pfizer-BioNTech Pfizer/BNT vaccine primary antibody reduced reported response responses robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2-specific CD8 T cells significantly lower subject T cell response the patient vaccination were stained X-linked agammaglobulinemia XLA XLA. [DOI] 10.1007/s10875-022-01256-y PMC 바로가기 [Article Type] Article
Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 – An open-label randomized controlled pilot studyShort communication Published on 2022-07-012022-10-05 Journal: Journal of Ayurveda and Integrative Medicine [Category] 신약개발, [키워드] adverse events all-cause mortality approach asymptomatic patient Ayurveda AYUSH 64 baseline benefit Clinical improvement conducted control group COVID 19 COVID-19 patient COVID19 COVID19 patients death Disease progression dose Effect Efficacy and safety evaluate group groups Impact incidence Inconclusive Indian traditional system of medicine invasive malaria material mechanical ventilator Mild Mortality Open-label outcome outcomes Oxygen therapy patients per day pilot study proportion Randomized reduction in Result SARS-CoV-2 Standard of care statistically significant difference Symptom symptom duration symptomatic treat ventilator was reduced WHO ordinal scale [DOI] 10.1016/j.jaim.2022.100587 [Article Type] Short communication
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patientsResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] COVID19(2023년), SARS, 신약개발, [키워드] 95% CI addition Admission age anti-inflammatory properties association cardiovascular diseases Chronic kidney disease CKD cohort study condition conditions Corticosteroids COVID COVID-19 COVID-19 infected patients COVID-19 patient COVID19 decrease diabetes evaluated groups hospital Hospitalization hospitalized COVID-19 patients hospitalized patient hypertension ICU ICU admission implementation Inflammatory marker inhibitor intensive care Mortality mortality rate notable Odds ratio outcome proportion Result SARS-CoV-2 severity Sex shown significant difference significantly single-center statin statins statistical analysis Statistics stroke Tehran variable was performed [DOI] 10.1016/j.therap.2021.10.006 [Article Type] Research article
Assessing the effect of blood type on death and a novel scoring system to assess clinical course in patients with COVID-19Article Published on 2022-07-012023-07-07 Journal: The American journal of the medical sciences [Category] COVID19(2023년), [키워드] age blood type Comorbidities COVID19 Gender morbidity Mortality scoring system [DOI] 10.1016/j.amjms.2021.12.006 PMC 바로가기
Clinical characteristics, risk factors, and rate of severity of a nationwide COVID-19 Saudi cohortResearch article Published on 2022-07-012022-10-05 Journal: Saudi Journal of Biological Sciences [Category] 임상, [키워드] 95% CI age Analysis baseline Characteristics clinical Clinical characteristics clinical factor Clinical severity Cohort Comorbidity COVID-19 COVID-19 case COVID-19 patients COVID-19 severity COVID19 COVID19 patient death rate Deceased demographic characteristics demographics Dexamethasone Diabetes Mellitus Elderly patient evaluate Favipiravir female patient Gender hazard highest Hospital stay Hospitalization Hospitalized hospitalized patient hypertension increased risk indicate Invasive mechanical ventilation invasive respiratory support Jeddah lymphocyte male Male sex medications Mortality multivariate logistic regression neutrophil obesity objective Odds ratio oxygen participant Patient prevalent prospective cohort study recruited required Result Risk factors Saudi Arabia severity stratified [DOI] 10.1016/j.sjbs.2022.103315 [Article Type] Research article
Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infectionSARS Cov2 원형, Delta 및 Omicron 변이체 감염을 억제하는 잠재적인 COVID-19 치료 화합물의 식별Article Published on 2022-07-012022-09-11 Journal: Virology [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료법, 치료제, [키워드] Anti-viral drug repurposing apilimod approach berbamine candidate drug cell death Cepharanthine clinical trial clinically Compound compounds COVID-19 COVID19 crizotinib Delta drug drug candidate effort FDA approval followed by Health identification Infection inhibit inhibited inhibitory effect less library multiple cell lines omicron Omicron variant Omicron variants Probability pseudovirus entry Recurrent replicated repurposing required robustness safety profile SARS CoV2 screened stratified Treatment Validity variant [DOI] 10.1016/j.virol.2022.05.004 PMC 바로가기 [Article Type] Article
Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisibleEditorial Published on 2022-07-012023-07-08 Journal: Reviews in Medical Virology [Category] COVID19(2023년), [키워드] COVID19 immunosuppressants Intravenous immunoglobulins polyclonal antibodies. SARS-CoV-2 [DOI] 10.1002/rmv.2341 [Article Type] Editorial